Literature DB >> 24508674

Purification of pre-miR-29 by arginine-affinity chromatography.

Patrícia Pereira1, Ângela Sousa1, João Queiroz1, Ilídio Correia1, Ana Figueiras2, Fani Sousa3.   

Abstract

Recently, differential expression of microRNAs, in patients with Alzheimer's disease (AD) suggests that they might have key regulatory roles in this neurodegenerative disease. Taking into account this fact, several studies demonstrated that the miR-29 is significantly decreased in AD patients, also displaying abnormally high levels of β-site APP-cleaving enzyme 1. Thus, RNA biochemical or structural studies often require a RNA sample that is chemically pure and biologically active. The present work describes a new affinity chromatography method using an arginine support to specifically purify pre-miR-29 from other Rhodovulum sulfidophilum small RNA species. Nevertheless, in order to achieve higher efficiency and selectivity, it is essential to characterize the behavior of pre-miR-29 binding/elution. Thus, three different strategies based on increased sodium chloride (280-500mM), arginine (25mM) or decreased ammonium sulfate (2-0.1M) stepwise gradients are described to purify pre-miR-29. In this way, it was proved that well-defined binding/elution conditions are crucial to enhance the purification performance. As a matter of fact, by employing elution strategies using sodium chloride or arginine, an improvement in the final pre-miR-29 yields (96.5 and 56.7%, respectively) was obtained. Moreover, the quality control analysis revealed high integrity in pre-miR-29 preparations as well as high purity (90 and 98%, respectively), demonstrated by the scarce detection of proteins. This improved method takes advantage of its simplicity, significant cost reduction, due to the elimination of some complex operations, and speed for large-scale purification of pre-miRNAs suitable for biochemical and structural studies.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Arginine-affinity chromatography; Multiple interactions; RNA purification; Rhodovulum sulfidophilum; pre-miR-29

Mesh:

Substances:

Year:  2014        PMID: 24508674     DOI: 10.1016/j.jchromb.2014.01.020

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  New insights for therapeutic recombinant human miRNAs heterologous production: Rhodovolum sulfidophilum vs Escherichia coli.

Authors:  Patrícia Pereira; Augusto Q Pedro; João A Queiroz; Ana R Figueiras; Fani Sousa
Journal:  Bioengineered       Date:  2017-03-10       Impact factor: 3.269

Review 2.  RNA therapy: Are we using the right molecules?

Authors:  Ai-Ming Yu; Chao Jian; Allan H Yu; Mei-Juan Tu
Journal:  Pharmacol Ther       Date:  2018-12-04       Impact factor: 12.310

3.  Cholinium-based Good's buffers ionic liquids as remarkable stabilizers and recyclable preservation media for recombinant small RNAs.

Authors:  Augusto Q Pedro; Patrícia Pereira; Maria J Quental; André P Carvalho; Sérgio M Santos; João A Queiroz; Fani Sousa; Mara G Freire
Journal:  ACS Sustain Chem Eng       Date:  2018-11-08       Impact factor: 8.198

Review 4.  Supported Ionic Liquids Used as Chromatographic Matrices in Bioseparation-An Overview.

Authors:  Sandra C Bernardo; Rita Carapito; Márcia C Neves; Mara G Freire; Fani Sousa
Journal:  Molecules       Date:  2022-02-28       Impact factor: 4.411

5.  Recombinant pre-miR-29b for Alzheimer´s disease therapeutics.

Authors:  Patrícia A Pereira; Joana F Tomás; João A Queiroz; Ana R Figueiras; Fani Sousa
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.